RDGL— VIVOS INC

Health Care$26M mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Revenues, net	$68K+144.3%	$28K+43.6%	$20K-46.6%	$36K
Cost of Goods Sold	$128K+313.6%	$31K+221.3%	-$26K+11.3%	-$29K
Gross (loss) profit	-$60K-1902.5%	-$3K+50.6%	-$6K-178.2%	$8K
Professional fees, including stock-based compensation	$2.0M+21.2%	$1.7M+4.7%	$1.6M-8.5%	$1.8M
Payroll expenses	$417K+18.3%	$353K+25.2%	$282K+2.4%	$275K
Research and development	$352K+8.5%	$325K-55.7%	$733K+113.1%	$344K
General and administrative expenses	$297K+22.6%	$242K+45.9%	$166K+9.7%	$151K
Total Operating Expenses	$3.1M+19.4%	$2.6M-6.7%	$2.8M+10.4%	$2.5M
OPERATING LOSS	-$3.2M-21.5%	-$2.6M+6.8%	-$2.8M-10.9%	-$2.5M
Interest income	$99K+32.2%	$75K+51.2%	$50K	—
Loss on issuance of shares and warrant exchange	-$381K	—	-$151K	—
Total Non-Operating Income	$99K+132.4%	-$306K-201.2%	-$102K-313.5%	$48K
NET LOSS BEFORE PROVISION FOR INCOME TAXES	-$3.1M-5.3%	-$2.9M-0.5%	-$2.9M-17.2%	-$2.5M
Provision for income taxes	—	—	—	—
NET LOSS	-$3.1M-5.3%	-$2.9M-0.5%	-$2.9M-17.2%	-$2.5M
Net loss per share - basic	-$0.01+0.0%	-$0.01+0.0%	-$0.01+0.0%	-$0.01
Net loss per share - diluted	-$0.01+0.0%	-$0.01+0.0%	-$0.01+0.0%	-$0.01
Weighted average common shares outstanding - basic	452.7M+10.5%	409.7M+11.1%	368.8M+4.9%	351.4M
Weighted average common shares outstanding - diluted	452.7M+10.5%	409.7M+11.1%	368.8M+4.9%	351.4M

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 12 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.